Suzanne Jones
10PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Nov 19, 2024
Open-Label, Multicenter, Phase I Study to Assess Safety and Tolerability of Adavosertib Plus Durvalumab in Patients with Advanced Solid Tumors.Manish R Patel, Gerald S Falchook, Judy S Wang
|Nov 02, 2024
Adavosertib in Combination with Olaparib in Patients with Refractory Solid Tumors: An Open-Label, Dose-Finding, and Dose-Expansion Phase Ib Trial.Erika P Hamilton, Gerald S Falchook, Judy S Wang
|Jun 06, 2023
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.Todd M Bauer, Kathleen N Moore, Janet S Rader
|May 12, 2023
A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors.Gerald S Falchook, Jasgit Sachdev, Esteban Rodrigo Imedio
|Jan 07, 2022
Tumor-Specific and Tumor-Agnostic Molecular Signatures Associated With Response to Immune Checkpoint Inhibitors.Daniel Schlauch, Xiaotong Fu, Suzanne F Jones
|Jan 07, 2022
Next-Generation Sequencing of Patients With Breast Cancer in Community Oncology Clinics.Emma G Sturgill, Amanda Misch, Rebecca Lachs
Pageof 2
Frequent Collaborators
5 joint publications
Esteban Rodrigo Imedio
4 joint publications
David Spigel
3 joint publications
Kathleen N Moore
3 joint publications
Erika P Hamilton
2 joint publications
Mark D Stewart
2 joint publications
Elaine Chang
2 joint publications
David E Gerber
2 joint publications
Andrew J McKenzie
2 joint publications
Gerald S Falchook
2 joint publications
Manish R Patel
